Cell Line Development

Global Market Trajectory & Analytics

MCP10946

EXECUTIVE ENGAGEMENTS

POOL

2337
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

421
Interactions with Platform & by Email

PARTICIPANTS

72
Unique # Participated

VALIDATIONS

21
Responses Validated*

COMPANIES

44
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

138

PAGES

212

EDITION

8

PRICE

USD 5450

CODE

MCP10946


COMPETITIVE METRICS

COMPANY

D S N T

% *

A World of Buzz Limited

Abzena PLC

Ace Sensor Inc.

AdvanceCare - Gestao de ServiCos de Saude, S.A.

Alavie Srl

Alex Group S.R.L.

Allarco Entertainment 2008 Inc.

Alpha Group Company Limited

Amada Co., Ltd.

American Type Culture Collection (ATCC)

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Cell Line Development estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$10.7 Billion by 2027, growing at a CAGR of 12.3% over the analysis period 2020-2027. Equipment, one of the segments analyzed in the report, is projected to record a 12.5% CAGR and reach US$4.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Media segment is readjusted to a revised 12.8% CAGR for the next 7-year period.
The Cell Line Development market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 11.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.8% and 10.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9% CAGR.
In the global Accessories & Consumables segment, USA, Canada, Japan, China and Europe will drive the 6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$242 Million in the year 2020 will reach a projected size of US$380.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027.

SELECT PLAYERS

Abzena PLC; American Type Culture Collection (ATCC); Apath LLC; Bioceros; Catalent, Inc.; CELLforCURE; Cobra Biologics; Corning, Inc.; Cyagen US Inc.; Cytovance Biologics; Epistem Holdings PLC; EuBiologics Co., Ltd.; GE Healthcare; GVK Biosciences Private Limited; Hitachi Chemical Advanced Therapeutics Solutions, LLC; Lonza Group Ltd.; MilliporeSigma; NAEJA-RGM Pharmaceuticals, Inc.; Paragon Bioservices, Inc.; Patheon, Inc.; Promocell GmbH; Samsung BioLogics; Sartorius AG; Selexis SA; Thermo Fisher Scientific, Inc.; WuXi AppTec

SEGMENTS

» Application (Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) » Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line) » Product Type (Equipment, Reagents & Media, Accessories & Consumables) » Source (Mammalian, Non-Mammalian)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Cell Line Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Cell Line Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Reagents & Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Reagents & Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Accessories & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Accessories & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Bioproduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Bioproduction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Tissue Engineering & Regenerative medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Tissue Engineering & Regenerative medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Toxicity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Toxicity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Mammalian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Mammalian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Non-Mammalian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Non-Mammalian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Recombinant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Recombinant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Hybridomas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Hybridomas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Continuous Cell Line by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Continuous Cell Line by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Primary Cell Line by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Primary Cell Line by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
USA Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
USA Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
USA Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
Canada Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
Canada Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
Canada Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
Japan Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
Japan Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
Japan Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
China Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
China Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
China Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Cell Line Development by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Cell Line Development by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
Europe Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
Europe Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
Europe Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
France Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
France Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
France Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
Germany Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
Germany Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
Germany Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
Italy Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
Italy Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
Italy Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
UK Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
UK Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
UK Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Cell Line Development by Product Type - Equipment, Reagents & Media and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Cell Line Development by Product Type - Percentage Breakdown of Value Sales for Equipment, Reagents & Media and Accessories & Consumables for the Years 2020 & 2027
Rest of World Current & Future Analysis for Cell Line Development by Application - Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Cell Line Development by Application - Percentage Breakdown of Value Sales for Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research and Drug Discovery for the Years 2020 & 2027
Rest of World Current & Future Analysis for Cell Line Development by Source - Mammalian and Non-Mammalian - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Cell Line Development by Source - Percentage Breakdown of Value Sales for Mammalian and Non-Mammalian for the Years 2020 & 2027
Rest of World Current & Future Analysis for Cell Line Development by Cell Line - Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Cell Line Development by Cell Line - Percentage Breakdown of Value Sales for Recombinant, Hybridomas, Continuous Cell Line and Primary Cell Line for the Years 2020 & 2027
Total Companies Profiled: 44

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com